Knowledge hub

Knowledge hub
Blog

Future perspectives for CAR-T cell therapies

Microbiome mysteries: What happens in the gut does not stay in the gut
Ardigen and The BioCollective partner to detect early signs of Parkinson’s Disease for better diagnosis and treatment.
5 years for precision medicine – Ardigen’s anniversary
Reading the genome – predictions of phenotypes
AI aided design of epitope-based vaccine for the induction of cellular immune responses against SARS-CoV-2
Agnieszka Blum, PhD MD, joins Ardigen as the General Director of Immunology
Ardigen has received funding to accelerate its AI-driven TCR discovery platform for novel cell therapies
PRISM – a writing assistant for the language of proteins
Blog

AI aided design of epitope-based vaccine for the induction of cellular immune responses against SARS-CoV-2

Leveraging biomarkers to bring the right treatment to the right patient
Ardigen enters into research collaboration with CVC to apply Artificial Intelligence for identification of T-cell targets – press release
Fishing out hypotheses from a sea of data: how Ardigen’s AIKE helps scientists ask better questions
AACR poster -2
Microbial signatures of response to anti-PD1 therapy in metastatic melanoma patients
AACR poster – 1
Accounting for immune escape mechanisms in personalized and shared neoantigen cancer vaccine design
Understanding microbial proteins with deep learning – part 2
Understanding microbial proteins with deep learning – part 1
Selvita and Ardigen will receive funding for the development of an AI-based high-content screening platform
  • Services
  • Technology
Social Media
United States

611 Gateway Boulevard
South San Francisco, CA 94080
USA
tel.+1 628 200 09 14

One Broadway, 14th Floor
Cambridge, MA 02142
USA
tel.+1 628 200 09 14

European Union

Sternbacha 1
30-394 Kraków
Poland
tel.+48 12 340 94 94